Company

Alkermes plc

Headquarters: Dublin, Ireland

Founded: 1987

Employees: 2,211

CEO: Mr. Richard F. Pops

NASDAQ: ALKS -0.37%

Market Cap

$4.77 Billion

USD as of Jan. 1, 2024

history Market Cap History

Alkermes plc market capitalization over time

Evolution of Alkermes plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Alkermes plc

Detailed Description

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Top 1-year algo backtest: +240.10%

$10,000 in February 2023 would now be $34,010 by following it 5 minutes per day at market close.

How much did you gain in the last 12 months?

Stocks & Indices

Alkermes plc has the following listings and related stock indices.


Stock: NASDAQ: ALKS wb_incandescent

Stock: FSX: 8AK wb_incandescent

Key People

Founder(s): Michael Wall

Richard Pops, CEO

Financials

Revenue: US$1 billion (2018)

Operating income: US$-42.9 Million

Net income: US$-39.6 Million


Total assets: US$452 Million

Total equity: US$392 Million

Details

Headquarters:

Connaught House

1 Burlington Road

Dublin, 4

Ireland

Phone: 353 1 772 8000